Skip to main content

Table 3 Immunostaining results of other markers studied.

From: Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma*

   ECA EMMA p-value
ER Score 0–3 11/14 (79%) 1/18 (6%) <0.001
  Score 4–12 3/14 (21%) 17/18 (94%)  
  Median (Range) 0 (0–12) 7.5 (2–12) <0.001
PR Score 0–3 11/14 (79%) 2/18 (11%) <0.001
  Score 4–12 3/14 (21%) 16/18 (89%)  
  Median (Range) 0 (0–12) 9 (1–12) <0.001
Vim Score 0–3 13/14 (93%) 9/18 (50%) 0.01
  Score 4–12 1/14 (7%) 9/18 (50%)  
  Median (Range) 0 (0–2) 1.5 (0–9) 0.002
  1. ECA, endocervical adenocarcinoma; EMMA, endometrial mucinous adenocarcinoma; NS, not significant.